Why the study?
Does catheter ablation of the atrioventricular junction improve symptom control in patients with accessory pathways and symptomatic atrioventricular reciprocating tachycardia?
Does catheter ablation of the atrioventricular junction improve symptom control in patients with accessory pathways and symptomatic atrioventricular reciprocating tachycardia?
Catheter ablation of the atrioventricular junction is effective for controlling refractory atrioventricular reciprocating tachycardia in patients with accessory pathways, though it is associated with a risk of subsequent atrial arrhythmias.
May support AV junction ablation for refractory AVRT symptom control; leaves open atrial arrhythmia risks and need for larger studies.
Seven patients with accessory pathway and symptomatic atrioventricular reciprocating tachycardia underwent catheter ablation of the atrioventricular junction (AVJ). Four patients had the Wolff-Parkinson-White syndrome, two had concealed left free-wall accessory pathways, and one patient had a nodoventricular connection. All patients failed multiple antiarrhythmic drugs and one failed attempted surgical ablation of a posteroseptal accessory pathway. Chronic interruption of atrioventricular node-His conduction was achieved in all patients. Over a mean follow-up period of 21 +/- 14 months, four patients remained asymptomatic without antiarrhythmic therapy. One patient developed atrial fibrillation after magnet application to her VVI pacemaker, another developed atrial flutter, and a third had nonparoxysmal sinus or atrial tachycardia. Two patients required chronic quinidine therapy. Two patients with concealed accessory pathways had pacemaker-mediated tachycardia which was controlled by pacemaker reprogramming. Atrioventricular junctional ablation in patients with accessory pathways proved effective in that all are currently controlled without need for surgical intervention. On follow-up, a relatively high incidence of atrial arrhythmias requiring antiarrhythmic therapy was found.
No takes yet. Share an insight, caveat, or question.
Eldar et al. (1986) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: